Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitapivat versus placebo in sickle cell disease
NL-OMON60241Phase 3Active, not recruiting
- Sponsor
- Agios Pharmaceuticals
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mitapivat, sponsored by Agios Pharmaceuticals. Started Aug 2024; status: active, not recruiting.
02
Drugs
mitapivat
Beyond the preview
Go deeper on NL-OMON60241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60241.